SB-728mR-HSPC Infusion 3 days following busulfan conditioning
14017
Phase 1 gene_therapy active
Quick answer
SB-728mR-HSPC Infusion 3 days following busulfan conditioning for HIV is a Phase 1 program (gene_therapy) at SANGAMO THERAPEUTICS, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SANGAMO THERAPEUTICS, INC
- Indication
- HIV
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- active